AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2023
May 1, 2023
30786_dirs_2023-05-01_315fd1f9-2766-4e1c-8799-62813ff16eab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-04-29
Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-29 | Bio-Rad A Common Stock | M | 1000 | — | Acquired | 4112.6151 | Direct |
| 2023-04-29 | Bio-Rad A Common Stock | F | 346 | $450.7900 | Disposed | 3766.6151 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-29 | Restricted Stock Units | $0 | M | 1000 | Disposed | Bio-Rad A Common Stock (1000) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.